The aim of this study was to assess the incidence of late onset complications of totally implantable venous access devices (TIVAD) in patients with cystic fibrosis (CF) and to investigate possible associations between the rate of complications and different policies of TIVAD management. METHODS: A multicenter prospective cohort study was performed in 11 Italian CF Centers. Patients with CF and a TIVAD were recruited and followed-up. RESULTS: The study commenced on May 2008 and ended on September 2010. Eighty subjects were studied (77.5% women--mean age 27.2 years). Eighteen late complications of ports were observed (22.5%; incidence 0.96 per 1000 days of observation): three lumen occlusions, seven catheter-related infections , three port-related venous thrombosis, in addition to five other complications. A statistically significant association was found between the onset of catheter-related infection and the presence of CF-related diabetes (CFRD) (P=.0064) CONCLUSIONS: Our data suggest that TIVADs represent a safe and effective device for the intermittent IV administration of drugs in people with CF. However, people with CFRD have a higher risk of developing TIVAD-related infection.

Totally Implantable Central Venous Access Ports in people with cystic fibrosis: a multicenter prospective cohort study / Dal Molin A;Di Massimo DS; Braggion C; Bisogni S; Rizz E;D’Orazio C;Di Toppa MV;Alghisi F; Cristadoro S; Del Vecchio S; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML ; Calamia M; Zunino ML ; Tuccio G; Spadea V; Messore B; Grosso B; Festini F.. - In: THE JOURNAL OF VASCULAR ACCESS. - ISSN 1724-6032. - STAMPA. - 13:(2012), pp. 290-295. [10.5301/jva.5000036]

Totally Implantable Central Venous Access Ports in people with cystic fibrosis: a multicenter prospective cohort study

BISOGNI, SOFIA;FESTINI, FILIPPO
2012

Abstract

The aim of this study was to assess the incidence of late onset complications of totally implantable venous access devices (TIVAD) in patients with cystic fibrosis (CF) and to investigate possible associations between the rate of complications and different policies of TIVAD management. METHODS: A multicenter prospective cohort study was performed in 11 Italian CF Centers. Patients with CF and a TIVAD were recruited and followed-up. RESULTS: The study commenced on May 2008 and ended on September 2010. Eighty subjects were studied (77.5% women--mean age 27.2 years). Eighteen late complications of ports were observed (22.5%; incidence 0.96 per 1000 days of observation): three lumen occlusions, seven catheter-related infections , three port-related venous thrombosis, in addition to five other complications. A statistically significant association was found between the onset of catheter-related infection and the presence of CF-related diabetes (CFRD) (P=.0064) CONCLUSIONS: Our data suggest that TIVADs represent a safe and effective device for the intermittent IV administration of drugs in people with CF. However, people with CFRD have a higher risk of developing TIVAD-related infection.
2012
13
290
295
Dal Molin A;Di Massimo DS; Braggion C; Bisogni S; Rizz E;D’Orazio C;Di Toppa MV;Alghisi F; Cristadoro S; Del Vecchio S; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML ; Calamia M; Zunino ML ; Tuccio G; Spadea V; Messore B; Grosso B; Festini F.
File in questo prodotto:
File Dimensione Formato  
13.Journal Vascula Access_2012.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 78.39 kB
Formato Adobe PDF
78.39 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/651159
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact